9,708
Total Claims
$1.4M
Drug Cost
1,194
Beneficiaries
$1,183
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
-22%
Cost per patient vs peers
$1,183 vs $1,524 avg
+21%
Brand preference vs peers
16.5% vs 13.7% avg
Brand vs Generic
84% generic
Brand: 1,606 claims · $1.2M
Generic: 8,102 claims · $237K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 602 | $537K |
| Rivaroxaban | 210 | $181K |
| Sacubitril/Valsartan | 153 | $157K |
| Evolocumab | 141 | $105K |
| Ticagrelor | 99 | $60K |
| Dapagliflozin Propanediol | 50 | $41K |
| Alirocumab | 40 | $32K |
| Dronedarone Hcl | 23 | $22K |
| Rosuvastatin Calcium | 446 | $18K |
| Ranolazine | 116 | $17K |
| Metoprolol Succinate | 694 | $15K |
| Atorvastatin Calcium | 691 | $14K |
| Ezetimibe | 250 | $13K |
| Empagliflozin | 20 | $12K |
| Dabigatran Etexilate Mesylate | 26 | $8,684 |
Prescribing Profile
76
Unique Drugs
$928K
Patient Profile
74
Avg Age
49%
Female
1.57
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data